indexado en
  • Abrir puerta J
  • Genamics JournalSeek
  • CiteFactor
  • Cosmos SI
  • cimago
  • Directorio de publicaciones periódicas de Ulrich
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • Directorio de indexación de resúmenes para revistas
  • OCLC-WorldCat
  • Convocatoria de búsqueda
  • erudito
  • CAMINO
  • Biblioteca Virtual de Biología (vifabio)
  • Publón
  • Fundación de Ginebra para la Educación e Investigación Médica
  • Google Académico
Comparte esta página
Folleto de diario
Flyer image

Abstracto

Evaluation of Angiogenic Potential of 1-Monocaproin Using Chick Chorioallantoic Membrane Assay

Palaniappan Maheswari and Kasthuri Revathi

1-Monocaproin, a 1-monoacylglycerol, was synthesized with the reaction of glycidol by chromium-caproic fatty acid complexes and was found to be amphiphilic in nature. Synthesized 1-monocaproin was characterized by thin-layer chromatography, and the residual chromium was analyzed using inductively coupled plasma mass spectroscopy. Vascular endothelium growth factor (VEGF)-mediated angiogenesis pathways are being targeted for the development of novel drugs suitable for inhibition or stimulation of angiogenesis in various pathologies. In the chicken egg Chorioallantoic membrane (CAM) assay, 1-monocaproin exhibited VEGF-induced neovascularization in a dose-dependent manner. Synthesized 1-monocaproin was found to show the angiogenic effect at a dose concentration equivalent to VEGF at 1,000 ppm. The results thus suggest that 1-monocaproin should be considered as a useful drug candidature targeting angiogenesis in coronary artery disease, stroke, and postsurgical therapy.